LATE-BREAKING ABSTRACT: High-efficacy transduction of tyrosine-mutant adeno-associated virus serotype 8 vector in pulmonary gene therapy.

S. Martini, A. Silva, D. Ferreira, K. Gomes, F. Ornellas, M. Pacheco, H. Petrs-Silva, P. Rocco, M. Morales (Rio de Janeiro, Brazil)

Source: International Congress 2014 – Latest insights in airway diseases
Session: Latest insights in airway diseases
Session type: Thematic Poster Session
Number: 2820

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Martini, A. Silva, D. Ferreira, K. Gomes, F. Ornellas, M. Pacheco, H. Petrs-Silva, P. Rocco, M. Morales (Rio de Janeiro, Brazil). LATE-BREAKING ABSTRACT: High-efficacy transduction of tyrosine-mutant adeno-associated virus serotype 8 vector in pulmonary gene therapy.. Eur Respir J 2014; 44: Suppl. 58, 2820

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.
Source: International Congress 2014 – COPD exacerbations
Year: 2014

LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV)
Source: International Congress 2014 – Respiratory infections in children
Year: 2014

LATE-BREAKING ABSTRACT: Inhibition of RC kinase is a novel therapeutic approach for the treatment of COPD and IPF
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Neuronal toll-like receptor (TLR) 7 expression and function in human airways
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


Decametoxine efficiency in the treatment of infectious exacerbation of asthma
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014


LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016


IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


LATE-BREAKING ABSTRACT: Discovering new treatments for asthma and COPD. The use of the human viral challenge model with a newly manufactured and characterised GMP human rhinovirus
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016

LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Comparative lentiviral versus adenoviral gene transfer of GM-CSF to bone marrow-derived versus pulmonary macrophages of mice
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015

Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014


In vivo effects of corticosteroid plus long-acting beta2-agonist on the expression of B7-H1/PD-L1 in double-stranded RNA-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014


Induction of galectin-9 production by viral infection in the lung
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015

Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Adeno-associated virus serotype 5 efficiently transduces human respiratory epithelium
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001

Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014

LATE-BREAKING ABSTRACT: A phase 2a study of benralizumab in adults with COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014